Target Price | CHF29.94 |
Price | CHF22.57 |
Potential | 32.67% |
Number of Estimates | 20 |
20 Analysts have issued a price target UBS Group 2026 . The average UBS Group target price is CHF29.94. This is 32.67% higher than the current stock price. The highest price target is CHF36.04 59.69% , the lowest is CHF19.92 11.75% . | |
A rating was issued by 23 analysts: 10 Analysts recommend UBS Group to buy, 6 to hold and 7 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the UBS Group stock has an average upside potential 2026 of 32.67% . Most analysts recommend the UBS Group stock at Purchase. |
15 Analysts have issued a sales forecast UBS Group 2025 . The average UBS Group sales estimate is CHF41.0b . This is 46.48% lower than the revenue of the last 12 months(TTM). The highest sales forecast is CHF43.3b 43.36% , the lowest is CHF38.9b 49.21% .
This results in the following potential growth metrics:
2024 | CHF76.5b | 18.99% |
---|---|---|
2025 | CHF41.0b | 46.46% |
2026 | CHF42.3b | 3.17% |
2027 | CHF44.0b | 4.07% |
2028 | CHF47.7b | 8.36% |
13 UBS Group Analysts have issued a net profit forecast 2025. The average UBS Group net profit estimate is CHF5.1b . This is 14.64% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF6.0b 35.04% , the lowest is CHF4.2b 5.42% .
This results in the following potential growth metrics and future Net Margins:
2024 | CHF4.4b | 82.05% |
---|---|---|
2025 | CHF5.1b | 14.64% |
2026 | CHF8.4b | 64.59% |
2027 | CHF11.3b | 34.56% |
2028 | CHF12.0b | 6.20% |
2024 | 5.81% | 84.92% |
---|---|---|
2025 | 12.44% | 114.14% |
2026 | 19.84% | 59.49% |
2027 | 25.66% | 29.33% |
2028 | 25.15% | 1.99% |
13 Analysts have issued a UBS Group forecast for earnings per share. The average UBS Group EPS is CHF1.60 . This is 14.29% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF1.89 35.00% , the lowest is CHF1.32 5.71% .
This results in the following potential growth metrics and future valuations:
2024 | CHF1.40 | 82.05% |
---|---|---|
2025 | CHF1.60 | 14.29% |
2026 | CHF2.64 | 65.00% |
2027 | CHF3.55 | 34.47% |
2028 | CHF3.78 | 6.48% |
Current | 16.63 | 441.69% |
---|---|---|
2025 | 14.49 | 12.87% |
2026 | 8.81 | 39.20% |
2027 | 6.54 | 25.77% |
2028 | 6.16 | 5.81% |
Based on analysts' sales estimates for 2025, the UBS Group stock is valued at an EV/Sales of 5.19 and an P/S ratio of 1.80 .
This results in the following potential growth metrics and future valuations:
Current | 2.78 | 19.65% |
---|---|---|
2025 | 5.19 | 86.71% |
2026 | 5.03 | 3.07% |
2027 | 4.83 | 3.91% |
2028 | 4.46 | 7.71% |
Current | 0.96 | 31.18% |
---|---|---|
2025 | 1.80 | 86.83% |
2026 | 1.75 | 3.07% |
2027 | 1.68 | 3.91% |
2028 | 1.55 | 7.71% |
Analyst | Rating | Action | Date |
---|---|---|---|
DAY BY DAY |
Buy
➜
Buy
|
Unchanged | Dec 08 2024 |
HSBC |
Buy
➜
Buy
|
Unchanged | Nov 24 2024 |
LANDESBANK BADEN-WUERTTEMBERG |
Hold
➜
Hold
|
Unchanged | Nov 10 2024 |
BANCO SANTANDER |
Neutral
➜
Neutral
|
Unchanged | Nov 07 2024 |
BNP PARIBAS EXANE |
Neutral
➜
Neutral
|
Unchanged | Nov 07 2024 |
BERENBERG |
Buy
➜
Buy
|
Unchanged | Oct 01 2024 |
DZ BANK |
Buy
➜
Buy
|
Unchanged | Sep 08 2024 |
Analyst Rating | Date |
---|---|
Unchanged
DAY BY DAY:
Buy
➜
Buy
|
Dec 08 2024 |
Unchanged
HSBC:
Buy
➜
Buy
|
Nov 24 2024 |
Unchanged
LANDESBANK BADEN-WUERTTEMBERG:
Hold
➜
Hold
|
Nov 10 2024 |
Unchanged
BANCO SANTANDER:
Neutral
➜
Neutral
|
Nov 07 2024 |
Unchanged
BNP PARIBAS EXANE:
Neutral
➜
Neutral
|
Nov 07 2024 |
Unchanged
BERENBERG:
Buy
➜
Buy
|
Oct 01 2024 |
Unchanged
DZ BANK:
Buy
➜
Buy
|
Sep 08 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.